Using the WARIFA app to promote healthy lifestyles and manage Type 1 Diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the WARIFA app's effectiveness in encouraging healthy lifestyle behaviors and managing Type 1 Diabetes (T1D) through personalized recommendations based on user-generated data and artificial intelligence. Participants will be divided into two groups: the general population with no more than one non-communicable disease (NCD) and individuals with T1D. The study aims to assess both the impact of the app on health outcomes and the feasibility of implementing such a health intervention. Outcomes will be measured to determine the app's effectiveness in promoting health and preventing NCDs.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Common for both population groups:
* Adults over 18 years of age.
* Owners of a smartphone operating with Android and with internet access.
* Group 1: General population:
* Healthy or diagnosed with no more than one NCD (CVD, any type of cancer, T2D or chronic respiratory disease).
* Group 2: T1D:
* Treatment with multiple subcutaneous insulin injections or an insulin pump.
* Users of a continuous glucose monitor.

Exclusion Criteria:

* Common for both groups:
* Pregnancy.
* Mobile device which is incompatible with the WARIFA app (E.g. Apple devices).
* Unable to understand any of the app languages (Spanish, English, Norwegian or Romanian).
* Any reason which precludes follow-up, based on the researcher's criteria.
* Group 1: General population
* People with two or more NCDs.

Where it's running

• Instituto Universitario De Investigaciones Biomédicas y Sanitarias (IUIBS)
  Las Palmas de Gran Canaria, Las Palmas, Spain Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Benefits of Retained Insulin for Good Health in Diabetes

  This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.

  Recruiting at 4 sites Royal Devon and Exeter NHS Foundation Trust · Truro, Cornwall and 3 other locations · NCT07828626

• Low-calorie diet with intensive lifestyle coaching to help diabetes remission in adults with Type 2 diabetes and overweight

  This study tests whether a strict low-calorie diet plus personalized lifestyle support can help adults with overweight Type 2 diabetes achieve diabetes remission more often than standard care.

  Recruiting Chulalongkorn University · Bangkok · NCT07748949

• Intermittent CGM Use in high-risk children and teens with Type 1 Diabetes in the Dominican Republic

  This study tests whether using the Dexcom G7 intermittently, along with pediatric care and support, can improve glucose control in 10–19 year-olds with high-risk Type 1 Diabetes in the Dominican Republic.

  Recruiting at 3 sites Life for a Child Program, Diabetes Australia · Santiago de los Caballeros and 2 other locations · NCT07742306

• AI-assisted remote insulin pump optimization for people with type 1 diabetes

  This study tests an AI-powered tool that suggests insulin pump settings for people with type 1 diabetes, with doctor-approved recommendations delivered to a mobile app.

  Recruiting The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Nanjing, Jiangsu · NCT07732777

• AMX0035 in adults with Type 1 Diabetes

  This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.

  Recruiting Phase 2 University of Washington · Seattle, Washington and 1 other locations · NCT07699380

• Enhanced Music and Natural Visuals for Emotional Health

  This trial tests whether using soundBrilliance software with music and natural visuals helps improve emotional health for people 13 and older.

  Recruiting at 3 sites soundBrilliance LLC · Fort Collins, Colorado and 2 other locations · NCT07676110

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.